Drug Safety Information for VOTRIENT (Pazopanib hydrochloride)
Safety-related Labeling Changes for VOTRIENT (PAZOPANIB HYDROCHLORIDE) Rx Drug: FDA Link
Adverse Drug Reactions for VOTRIENT* (Pazopanib hydrochloride)
These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).
Top 20 Adverse Effects Associated with VOTRIENT
(reported in FDA Medwatch/FAERS Reports)
Side Effect | # of FDA Reports | |
---|---|---|
1 | Diarrhoea* | 1305 |
2 | Death | 1273 |
3 | Nausea | 1002 |
4 | Fatigue | 980 |
5 | Vomiting | 583 |
6 | Decreased appetite | 548 |
7 | Drug ineffective | 502 |
8 | Hypertension | 481 |
9 | Disease progression | 431 |
10 | Blood pressure increased | 344 |
11 | Asthenia | 323 |
12 | Weight decreased | 322 |
13 | Hair colour changes | 321 |
14 | Dyspnoea | 302 |
15 | Headache | 269 |
16 | Malaise | 260 |
17 | Neoplasm malignant | 255 |
18 | Dysgeusia | 232 |
19 | Abdominal pain | 218 |
20 | Pain | 207 |
* This side effect also appears in "Top 10 Side Effects of VOTRIENT " in the drug's Review Summary based on AskaPatient reviews.
Top 10 Reasons for Taking VOTRIENT
(associated with FDA Medwatch/FAERS Reports)
Reason | # of FDA Reports | |
---|---|---|
1 | Renal cancer | 6063 |
2 | Renal cell carcinoma | 3970 |
3 | Product used for unknown indication | 3787 |
4 | Sarcoma | 1109 |
5 | Metastatic renal cell carcinoma | 1001 |
6 | Renal cancer metastatic | 762 |
7 | Neoplasm malignant | 749 |
8 | Malignant urinary tract neoplasm | 369 |
9 | Neoplasm | 361 |
10 | Leiomyosarcoma | 359 |
*Also a top-10 reason in AskaPatient Review Summary.
Types of Adverse Events for VOTRIENT
Total Reports Filed with FDA: 26689
Number of FDA Adverse Event Reports by Patient Age for VOTRIENT
Total Reports Filed with FDA: 26689*
* Reports for drugs with the same active ingredients have been aggregated in this analysis: Pazopanib hydrochloride (Votrient)
Charts are based on 26689 reports filed with the FDA between 2004 and June 2015.
Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.
Click to go back to search results and VOTRIENT Reviews and Review Summary .
Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.